Bank Julius Baer & Co. Ltd Zurich Has $39.36 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Bank Julius Baer & Co. Ltd Zurich cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 1.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 289,697 shares of the financial services provider’s stock after selling 3,400 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in iShares Biotechnology ETF were worth $39,355,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of IBB. International Assets Investment Management LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter valued at about $76,425,000. Itau Unibanco Holding S.A. bought a new position in iShares Biotechnology ETF in the third quarter valued at about $48,242,000. Tower Research Capital LLC TRC raised its position in iShares Biotechnology ETF by 28,138.4% in the third quarter. Tower Research Capital LLC TRC now owns 98,552 shares of the financial services provider’s stock valued at $12,052,000 after purchasing an additional 98,203 shares during the last quarter. Calamos Advisors LLC bought a new position in iShares Biotechnology ETF in the fourth quarter valued at about $7,648,000. Finally, Cumberland Advisors Inc. bought a new position in iShares Biotechnology ETF in the third quarter valued at about $6,297,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

IBB traded up $0.82 during trading on Friday, reaching $126.49. 833,034 shares of the company were exchanged, compared to its average volume of 1,795,944. The company’s 50-day moving average is $134.45 and its two-hundred day moving average is $129.71. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a dividend of $0.126 per share. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.40%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.